Sugar-binding fluorescent probes pick out insulin-deficient zebrafish from healthy siblings

Comparing mutant fish with their own healthy siblings ^[6] is the control I would look for first in a genetic disease model. The Bath team ran it alongside a second, separate test. In the first, the sugar came from outside the animal ^[5]. In the second, nothing was added, and the difference came from a mutation that leaves the fish short of insulin ^[6]. "Our results show that synthetic boronic acid-based fluorescent probes can report on glucose fluctuations caused by both external sugar exposure and insulin deficiency in a living organism," said Dr. David Gurevich, a corresponding author and Sir Henry Dale Wellcome Trust research fellow in Bath's Department of Life Sciences ^[8].

The signal moves in the opposite direction to the sugar. In the mutants, higher glucose came with lower fluorescence ^[7]. A dimmer probe in a sick animal can have more than one cause, so it matters exactly what was measured. MP-FLIM reads how long the fluorescence lasts instead of how bright it is ^[3]. The release does not say whether the diabetic drop showed up in lifetime or in brightness, how many fish were imaged, or how large the drop was beyond calling it significant ^[7].

The evidence covers cultured cells and zebrafish ^[4], a species widely used in metabolic research ^[16]. I think the sibling comparison is the part of this work a zebrafish diabetes lab can build on now. Diagnosis in people is further off. The probes would first have to work in mammals.

The researchers believe the platform could be adapted to detect other carbohydrates and metabolic markers, and could eventually support earlier diagnosis, drug discovery and personalized treatment ^[13]. "This represents an important step toward next-generation tools for investigating metabolic disorders and developing precision diagnostic technologies," said Professor Sofia I. Pascu of Bath's Department of Chemistry, a corresponding author ^[12]. Professor Tony D. James, a co-corresponding author, said the group is "now exploring how these technologies might be developed further for theranostic applications and future drug-screening tools" ^[14].

The paper, first-authored by Haobo Ge, is published in Advanced Science ^[9]. The team included the late Professor John S. Fossey of the University of Birmingham, a leading figure in boronic acid chemistry and molecular recognition ^[15].